| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Natural Killer T-Cells | 17 | 2024 | 124 | 7.000 |
Why?
|
| Neuroblastoma | 23 | 2023 | 686 | 4.050 |
Why?
|
| Cytotoxicity, Immunologic | 12 | 2024 | 675 | 1.690 |
Why?
|
| Immunotherapy, Adoptive | 12 | 2023 | 1763 | 1.470 |
Why?
|
| Lymphocyte Activation | 13 | 2024 | 1688 | 1.350 |
Why?
|
| Antigens, CD1d | 7 | 2019 | 32 | 1.220 |
Why?
|
| Gangliosides | 4 | 2019 | 95 | 1.160 |
Why?
|
| Interleukin-15 | 5 | 2020 | 185 | 1.110 |
Why?
|
| Killer Cells, Natural | 8 | 2023 | 904 | 1.070 |
Why?
|
| Receptors, Antigen, T-Cell | 10 | 2023 | 1146 | 0.920 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2023 | 26 | 0.910 |
Why?
|
| L-Selectin | 2 | 2018 | 34 | 0.730 |
Why?
|
| Galactosylceramides | 5 | 2018 | 34 | 0.700 |
Why?
|
| Interleukins | 2 | 2020 | 325 | 0.700 |
Why?
|
| Mice, SCID | 10 | 2023 | 1869 | 0.660 |
Why?
|
| Th1 Cells | 2 | 2018 | 250 | 0.650 |
Why?
|
| Cancer Vaccines | 5 | 2019 | 697 | 0.650 |
Why?
|
| Mice, Inbred NOD | 9 | 2023 | 905 | 0.630 |
Why?
|
| Receptors, Antigen | 2 | 2016 | 76 | 0.620 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2023 | 1538 | 0.620 |
Why?
|
| Lymphoma, B-Cell | 3 | 2018 | 895 | 0.580 |
Why?
|
| T-Lymphocyte Subsets | 4 | 2016 | 582 | 0.570 |
Why?
|
| Mice | 30 | 2023 | 34495 | 0.510 |
Why?
|
| Macrophages | 5 | 2014 | 1304 | 0.490 |
Why?
|
| Immunotherapy | 5 | 2019 | 3341 | 0.480 |
Why?
|
| Antigens, CD1 | 2 | 2003 | 49 | 0.440 |
Why?
|
| Animals | 32 | 2023 | 59536 | 0.420 |
Why?
|
| Neoplasms | 5 | 2023 | 15193 | 0.410 |
Why?
|
| Xenograft Model Antitumor Assays | 10 | 2020 | 3821 | 0.390 |
Why?
|
| Medulloblastoma | 2 | 2013 | 540 | 0.380 |
Why?
|
| T-Lymphocytes | 9 | 2023 | 3869 | 0.360 |
Why?
|
| Glypicans | 2 | 2020 | 51 | 0.320 |
Why?
|
| Bone Neoplasms | 2 | 2020 | 2576 | 0.320 |
Why?
|
| Antigen-Presenting Cells | 3 | 2019 | 284 | 0.310 |
Why?
|
| Chemokine CCL2 | 2 | 2007 | 203 | 0.300 |
Why?
|
| T-Lymphocytes, Cytotoxic | 3 | 2019 | 1016 | 0.290 |
Why?
|
| Oncogene Proteins | 2 | 2012 | 354 | 0.290 |
Why?
|
| Interleukin-2 | 2 | 2018 | 842 | 0.280 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2007 | 673 | 0.280 |
Why?
|
| Humans | 42 | 2024 | 261506 | 0.270 |
Why?
|
| Cells, Cultured | 6 | 2018 | 5637 | 0.260 |
Why?
|
| Cell Line, Tumor | 13 | 2019 | 14551 | 0.260 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 6550 | 0.250 |
Why?
|
| CD28 Antigens | 2 | 2016 | 202 | 0.250 |
Why?
|
| Cell Proliferation | 7 | 2020 | 7226 | 0.240 |
Why?
|
| Etanercept | 1 | 2023 | 54 | 0.230 |
Why?
|
| Cell Movement | 3 | 2012 | 2466 | 0.230 |
Why?
|
| Leukemia, Myelomonocytic, Acute | 1 | 2003 | 72 | 0.230 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2023 | 37 | 0.220 |
Why?
|
| Tumor Cells, Cultured | 6 | 2020 | 5395 | 0.220 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2023 | 77 | 0.220 |
Why?
|
| STAT3 Transcription Factor | 5 | 2015 | 1121 | 0.220 |
Why?
|
| Granzymes | 2 | 2018 | 91 | 0.220 |
Why?
|
| Cytokines | 6 | 2016 | 2809 | 0.220 |
Why?
|
| Macrophage-1 Antigen | 1 | 2002 | 51 | 0.220 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2002 | 84 | 0.210 |
Why?
|
| Antigens, CD19 | 2 | 2023 | 577 | 0.210 |
Why?
|
| Interleukin-7 | 2 | 2017 | 95 | 0.210 |
Why?
|
| Protein Domains | 1 | 2023 | 314 | 0.210 |
Why?
|
| Adjuvants, Immunologic | 3 | 2019 | 657 | 0.210 |
Why?
|
| Receptors, IgG | 1 | 2002 | 102 | 0.210 |
Why?
|
| Flow Cytometry | 3 | 2010 | 3033 | 0.200 |
Why?
|
| Neoplasm Transplantation | 4 | 2018 | 1519 | 0.200 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 2018 | 173 | 0.180 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2019 | 1555 | 0.180 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 1021 | 0.180 |
Why?
|
| Transduction, Genetic | 3 | 2019 | 475 | 0.170 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 1033 | 0.170 |
Why?
|
| Homeostasis | 1 | 2004 | 950 | 0.170 |
Why?
|
| Monocytes | 1 | 2023 | 788 | 0.170 |
Why?
|
| beta Catenin | 1 | 2023 | 688 | 0.170 |
Why?
|
| Neoplasm Metastasis | 5 | 2015 | 5112 | 0.170 |
Why?
|
| Antibodies | 1 | 2002 | 838 | 0.170 |
Why?
|
| CD3 Complex | 1 | 2019 | 314 | 0.170 |
Why?
|
| Neoplasms, Experimental | 2 | 2019 | 750 | 0.160 |
Why?
|
| Immunity | 1 | 2020 | 342 | 0.160 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2019 | 100 | 0.160 |
Why?
|
| Neutrophils | 1 | 2002 | 835 | 0.150 |
Why?
|
| Nuclear Proteins | 2 | 2012 | 3343 | 0.150 |
Why?
|
| Receptors, Granulocyte Colony-Stimulating Factor | 2 | 2015 | 35 | 0.150 |
Why?
|
| Salmonella typhimurium | 2 | 2014 | 70 | 0.150 |
Why?
|
| Vaccines, Attenuated | 2 | 2014 | 210 | 0.150 |
Why?
|
| Nanoparticles | 1 | 2021 | 554 | 0.140 |
Why?
|
| Carcinogenesis | 1 | 2023 | 1026 | 0.140 |
Why?
|
| Child | 6 | 2023 | 29154 | 0.140 |
Why?
|
| Tumor Necrosis Factor Receptor Superfamily, Member 9 | 1 | 2016 | 69 | 0.140 |
Why?
|
| Tumor Microenvironment | 4 | 2021 | 2864 | 0.130 |
Why?
|
| Vidarabine | 1 | 2020 | 1341 | 0.130 |
Why?
|
| N-Myc Proto-Oncogene Protein | 3 | 2013 | 82 | 0.130 |
Why?
|
| Glycolipids | 2 | 2019 | 58 | 0.130 |
Why?
|
| Apoptosis | 7 | 2020 | 7591 | 0.130 |
Why?
|
| Antigens, Neoplasm | 3 | 2019 | 1506 | 0.130 |
Why?
|
| 4-1BB Ligand | 1 | 2014 | 15 | 0.130 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 2 | 2015 | 749 | 0.130 |
Why?
|
| Contrast Media | 1 | 2021 | 1472 | 0.120 |
Why?
|
| Interleukin-6 | 2 | 2009 | 1038 | 0.120 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 376 | 0.120 |
Why?
|
| Retroviridae | 1 | 2014 | 332 | 0.120 |
Why?
|
| Cyclophosphamide | 1 | 2020 | 3001 | 0.110 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2011 | 202 | 0.110 |
Why?
|
| Hypoxia | 1 | 2016 | 443 | 0.110 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2020 | 5178 | 0.110 |
Why?
|
| Glycolysis | 1 | 2016 | 519 | 0.110 |
Why?
|
| Cell Survival | 2 | 2016 | 3045 | 0.110 |
Why?
|
| Peptides | 1 | 2019 | 1479 | 0.110 |
Why?
|
| Glycosphingolipids | 1 | 2012 | 60 | 0.110 |
Why?
|
| Salmonella enterica | 1 | 2012 | 12 | 0.110 |
Why?
|
| Bone Marrow | 3 | 2007 | 2358 | 0.110 |
Why?
|
| Cell Line | 2 | 2014 | 5114 | 0.100 |
Why?
|
| Immunotherapy, Active | 1 | 2011 | 46 | 0.100 |
Why?
|
| Antigens | 1 | 2012 | 292 | 0.100 |
Why?
|
| Chemotaxis | 1 | 2011 | 138 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 1487 | 0.100 |
Why?
|
| Models, Immunological | 1 | 2010 | 77 | 0.100 |
Why?
|
| Hematologic Neoplasms | 1 | 2022 | 1870 | 0.090 |
Why?
|
| Salmonella | 1 | 2010 | 35 | 0.090 |
Why?
|
| Drug Carriers | 1 | 2012 | 327 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2013 | 6150 | 0.090 |
Why?
|
| Virulence Factors | 1 | 2012 | 213 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 2 | 2015 | 1443 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 4367 | 0.090 |
Why?
|
| Melanoma, Experimental | 1 | 2011 | 368 | 0.080 |
Why?
|
| Glioblastoma | 2 | 2017 | 1797 | 0.080 |
Why?
|
| Vaccination | 2 | 2012 | 1123 | 0.080 |
Why?
|
| Immunophenotyping | 2 | 2003 | 1681 | 0.080 |
Why?
|
| Ligands | 2 | 2019 | 995 | 0.080 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 669 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 2027 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 534 | 0.070 |
Why?
|
| Cerebellar Neoplasms | 1 | 2011 | 434 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2016 | 5710 | 0.070 |
Why?
|
| Repressor Proteins | 2 | 2011 | 1664 | 0.070 |
Why?
|
| Melanoma | 2 | 2019 | 5317 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 7551 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2011 | 1048 | 0.060 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 2216 | 0.060 |
Why?
|
| Signal Transduction | 4 | 2017 | 11965 | 0.060 |
Why?
|
| Bone Marrow Cells | 1 | 2009 | 943 | 0.060 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 2359 | 0.060 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2003 | 16 | 0.060 |
Why?
|
| Cell Hypoxia | 2 | 2016 | 328 | 0.060 |
Why?
|
| Graft vs Host Disease | 1 | 2014 | 2638 | 0.060 |
Why?
|
| Child, Preschool | 4 | 2013 | 16273 | 0.060 |
Why?
|
| CD56 Antigen | 1 | 2003 | 83 | 0.060 |
Why?
|
| Perforin | 1 | 2003 | 52 | 0.060 |
Why?
|
| Thymus Gland | 1 | 2004 | 294 | 0.060 |
Why?
|
| RNA Interference | 1 | 2007 | 1408 | 0.060 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 4557 | 0.060 |
Why?
|
| Male | 6 | 2020 | 123000 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 2508 | 0.050 |
Why?
|
| Genes, myc | 1 | 2004 | 358 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2024 | 253 | 0.050 |
Why?
|
| DNA Primers | 1 | 2004 | 1399 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2003 | 275 | 0.050 |
Why?
|
| N-Acetylgalactosaminyltransferases | 1 | 2001 | 12 | 0.050 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2001 | 84 | 0.050 |
Why?
|
| Exocytosis | 1 | 2002 | 111 | 0.050 |
Why?
|
| Cytoplasmic Granules | 1 | 2002 | 89 | 0.050 |
Why?
|
| Immunomagnetic Separation | 1 | 2001 | 43 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2004 | 1062 | 0.050 |
Why?
|
| U937 Cells | 1 | 2001 | 171 | 0.050 |
Why?
|
| RNA, Neoplasm | 1 | 2004 | 771 | 0.050 |
Why?
|
| HL-60 Cells | 1 | 2001 | 302 | 0.050 |
Why?
|
| Jurkat Cells | 1 | 2001 | 311 | 0.050 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 2927 | 0.050 |
Why?
|
| Receptors, Interleukin-6 | 2 | 2012 | 62 | 0.050 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2002 | 408 | 0.050 |
Why?
|
| Protein Binding | 1 | 2007 | 3438 | 0.050 |
Why?
|
| Phenotype | 2 | 2013 | 6295 | 0.050 |
Why?
|
| Receptors, Vitronectin | 1 | 2000 | 24 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2004 | 3639 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 3101 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 4143 | 0.040 |
Why?
|
| Ceramides | 1 | 2000 | 95 | 0.040 |
Why?
|
| Female | 10 | 2020 | 141928 | 0.040 |
Why?
|
| Iodine Radioisotopes | 1 | 2021 | 371 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 709 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2019 | 6942 | 0.040 |
Why?
|
| Infant | 3 | 2012 | 13310 | 0.040 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2019 | 56 | 0.040 |
Why?
|
| Carcinoma, Small Cell | 1 | 2001 | 408 | 0.040 |
Why?
|
| Machine Learning | 1 | 2021 | 319 | 0.040 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2000 | 301 | 0.040 |
Why?
|
| Protein Engineering | 1 | 2019 | 100 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2001 | 14289 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2017 | 8873 | 0.040 |
Why?
|
| Integrins | 1 | 2000 | 262 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2003 | 1073 | 0.040 |
Why?
|
| K562 Cells | 1 | 2019 | 338 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 3203 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2001 | 1643 | 0.040 |
Why?
|
| Base Sequence | 1 | 2004 | 4917 | 0.040 |
Why?
|
| Chemokines | 1 | 2019 | 314 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2001 | 1144 | 0.040 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2019 | 193 | 0.040 |
Why?
|
| Adolescent | 3 | 2013 | 31252 | 0.040 |
Why?
|
| Receptors, Cytokine | 1 | 2017 | 176 | 0.040 |
Why?
|
| Epitopes | 1 | 2019 | 685 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2012 | 2314 | 0.040 |
Why?
|
| Transfection | 1 | 2001 | 2944 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 4053 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2011 | 992 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 3154 | 0.030 |
Why?
|
| Genome, Human | 1 | 2004 | 1869 | 0.030 |
Why?
|
| Radiometry | 1 | 2021 | 980 | 0.030 |
Why?
|
| Endothelium, Vascular | 1 | 2000 | 891 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2021 | 1987 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2016 | 208 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2016 | 343 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 10035 | 0.030 |
Why?
|
| Brain Neoplasms | 3 | 2010 | 4849 | 0.030 |
Why?
|
| Side-Population Cells | 1 | 2013 | 18 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2003 | 6100 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2015 | 4078 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2014 | 32848 | 0.030 |
Why?
|
| Th1-Th2 Balance | 1 | 2012 | 12 | 0.030 |
Why?
|
| Receptor, trkB | 1 | 2012 | 53 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2012 | 134 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2000 | 1248 | 0.030 |
Why?
|
| Chemokine CCL20 | 1 | 2012 | 39 | 0.030 |
Why?
|
| Salmonella Vaccines | 1 | 2012 | 7 | 0.030 |
Why?
|
| Stereoisomerism | 1 | 2012 | 164 | 0.030 |
Why?
|
| Adult | 3 | 2022 | 77950 | 0.030 |
Why?
|
| Hemolysin Proteins | 1 | 2012 | 27 | 0.030 |
Why?
|
| Dendritic Cells | 2 | 2010 | 1085 | 0.030 |
Why?
|
| Ovalbumin | 1 | 2012 | 254 | 0.030 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2011 | 34 | 0.020 |
Why?
|
| Chemokine CCL5 | 1 | 2011 | 71 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2003 | 5159 | 0.020 |
Why?
|
| Codon | 1 | 2011 | 241 | 0.020 |
Why?
|
| Bacterial Toxins | 1 | 2012 | 228 | 0.020 |
Why?
|
| Vaccines, Synthetic | 1 | 2012 | 355 | 0.020 |
Why?
|
| Salmonella Infections | 1 | 2010 | 40 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2012 | 311 | 0.020 |
Why?
|
| Calcium-Binding Proteins | 1 | 2012 | 545 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2012 | 1082 | 0.020 |
Why?
|
| Protein Transport | 1 | 2012 | 734 | 0.020 |
Why?
|
| Gene Amplification | 1 | 2012 | 731 | 0.020 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 487 | 0.020 |
Why?
|
| Virulence | 1 | 2010 | 323 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2004 | 13658 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 862 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 1029 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2009 | 342 | 0.020 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2009 | 132 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2015 | 4307 | 0.020 |
Why?
|
| Antigens, CD | 1 | 2012 | 1385 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2022 | 14889 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2014 | 1586 | 0.020 |
Why?
|
| Glycosylation | 1 | 2006 | 213 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2012 | 1555 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2011 | 1694 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2006 | 515 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2009 | 825 | 0.020 |
Why?
|
| Transcriptome | 1 | 2013 | 1859 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 2488 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2014 | 2819 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 4654 | 0.010 |
Why?
|
| Inflammation | 1 | 2012 | 2522 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2001 | 10331 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2010 | 1390 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 2001 | 38 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2004 | 15862 | 0.010 |
Why?
|
| Bone Marrow Purging | 1 | 2001 | 86 | 0.010 |
Why?
|
| Disease Progression | 1 | 2012 | 6682 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 2001 | 148 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 3552 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 10001 | 0.010 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2000 | 142 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2022 | 37905 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2013 | 2947 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 4821 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2001 | 11538 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2000 | 371 | 0.010 |
Why?
|
| Brain | 1 | 2011 | 4113 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2000 | 1764 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 21713 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 6089 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 4971 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2000 | 7548 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2001 | 8223 | 0.010 |
Why?
|